Typicality: | 0.413 |
Saliency: | 0.382 |
for diseases of the poor | 4 | purpose |
under licensing agreements | 2 | other |
incentive → invest in → r&d | 17 |
incentive → include → r&d | 4 |
negative | neutral | positive |
0.109 | 0.515 | 0.376 |
Raw frequency | 21 |
Normalized frequency | 0.382 |
Modifier score | 0.500 |
Perplexity | 13.266 |